Episode Details

Back to Episodes

Glaukos Issued J-Code for Recently Launched Epioxa

Published 1 month, 1 week ago
Description

Glaukos commercially launches its topical drug therapy for keratoconus; BVI’s next-generation phaco-vitrectomy surgical system receives CE Mark; and the ASCRS Executive Director recaps the 2nd annual Sightline meeting. 

Learn more about your ad choices. Visit megaphone.fm/adchoices

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us